Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative
Publication Date
5-1-2022
Document Type
Article
Publication Title
Oncology Nursing Forum
Volume
49
Issue
3
DOI
10.1188/22.onf.233-241
First Page
233
Last Page
241
Abstract
OBJECTIVES: To evaluate the effects of virtual reality (VR) on symptom distress, such as depression, anxiety, and pain, experienced by individuals receiving allogeneic hematopoietic stem cell transplantation. SAMPLE & SETTING: 20 participants aged 19–70 years (median age of 56.5 years) who were hospitalized in an academic setting received as many as two sessions of VR per week for two weeks. METHODS & VARIABLES: Before and after each session, participants completed the revised Edmonton Symptom Assessment Scale (ESAS-r) to evaluate their symptoms. Paired t tests were later conducted. RESULTS: VR sessions showed significant improvement in 8 of the 10 symptoms addressed in ESAS-r. IMPLICATIONS FOR NURSING: VR can improve symptoms in patients following hematopoietic stem cell transplantation in a hospital setting, provide a low-cost intervention to treat symptoms, and support future investigations exploring how VR affects prolonged hospitalizations related to distressing symptoms.
Keywords
comfort theory, stem cell transplantation, symptoms, virtual reality
Department
Nursing
Recommended Citation
Colleen Vega, Robin L. Whitney, Josef Hannah, and Grant Matthew Smith. "Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Quality Improvement Initiative" Oncology Nursing Forum (2022): 233-241. https://doi.org/10.1188/22.onf.233-241